컨텐츠 내용을 수정할 수 있습니다
These disorders follow exposure to a traumatic or stressful event, which is an explicit diagnostic requirement. Most people exposed to trauma recover naturally; a minority develop persistent disorders. Risk rises with trauma severity and duration, interpersonal violence, childhood adversity, prior mental illness, low social support, and ongoing stressors after the event.
Mechanisms — fear conditioning with failure of fear extinction; an overactive amygdala, reduced prefrontal (medial) regulation, and hippocampal changes that impair placing the memory in context; sympathetic (noradrenergic) hyperactivity; altered HPA axis function. Avoidance prevents new learning that reminders are now safe.
| Disorder | Key features |
|---|---|
| Posttraumatic stress disorder (PTSD) | Exposure to actual or threatened death, serious injury, or sexual violence (directly, witnessing, learning it happened to a close person, or repeated exposure to details, as in first responders). Symptoms last more than 1 month |
| Acute stress disorder (ASD) | Same exposure; ≥ 9 of 14 symptoms (intrusion, negative mood, dissociation, avoidance, arousal) lasting 3 days to 1 month after the trauma |
| Adjustment disorder | Emotional or behavioral symptoms within 3 months of an identifiable stressor (divorce, job loss, illness), out of proportion or impairing; resolve within 6 months after the stressor and its consequences end |
| Prolonged grief disorder (added in DSM-5-TR, 2022) | At least 12 months after a death (6 months in children and adolescents): intense yearning or preoccupation with the deceased nearly every day, with symptoms such as identity disruption, disbelief, avoidance of reminders, intense emotional pain, numbness, loneliness, difficulty re-engaging |
| Reactive attachment disorder | Young child with inhibited, emotionally withdrawn behavior toward caregivers after severe neglect; developmental age ≥ 9 months, evident before age 5 |
| Disinhibited social engagement disorder | Child with overly familiar behavior with strangers after severe neglect; developmental age ≥ 9 months |
| Cluster | Required | Examples |
|---|---|---|
| B. Intrusion (re-experiencing) | ≥ 1 | Distressing memories, nightmares, flashbacks (sounds, smells return vividly), distress or physical reaction to cues |
| C. Avoidance | ≥ 1 | Avoiding memories, thoughts, places, people, or activities linked to the trauma |
| D. Negative changes in cognition and mood | ≥ 2 | Amnesia for parts of the event, distorted blame of self or others, persistent fear, guilt, or shame, detachment, inability to feel positive emotions |
| E. Arousal and reactivity | ≥ 2 | Hypervigilance, exaggerated startle, irritability or aggression, reckless or self-destructive behavior, poor concentration, sleep disturbance |
Specifiers: with dissociative symptoms (depersonalization or derealization) and with delayed expression (full criteria not met until at least 6 months after the event). Children 6 years and younger have separate criteria; trauma often appears as repetitive play reenacting the event, frightening dreams without clear content, regression (bedwetting, loss of speech), and clinginess.
Complex PTSD is an ICD-11 diagnosis (not DSM-5-TR): PTSD plus persistent problems in affect regulation, negative self-concept, and relationships, usually after prolonged or repeated trauma such as childhood abuse or captivity.
| Tool | Use |
|---|---|
| Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) | Brief screening |
| PTSD Checklist for DSM-5 (PCL-5) | Symptom severity, monitoring |
| Clinician-Administered PTSD Scale (CAPS-5) | Structured diagnosis |
| Suicide screening (e.g., C-SSRS) | Safety |
| Drug and alcohol screening; TBI screening when relevant | Comorbidity |
| Drug | Key points |
|---|---|
| Sertraline, paroxetine (FDA-approved for PTSD), venlafaxine | Recommended when psychotherapy is unavailable, declined, or insufficient. Standard SSRI/SNRI safety: early activation, GI effects, sexual dysfunction, hyponatremia, bleeding risk, serotonin syndrome, suicidality boxed warning under 25, taper to stop; paroxetine has anticholinergic effects and strong discontinuation symptoms; venlafaxine raises BP |
| Prazosin | Suggested for trauma-related nightmares (not for PTSD symptoms overall). Alpha-1 blocker: first-dose orthostatic hypotension and syncope — give at bedtime, start low, rise slowly, monitor BP |
| Benzodiazepines | Recommended against — they do not treat PTSD, may interfere with recovery, and add dependence and overdose risk |
| Cannabis | Recommended against |
| Antipsychotics | Not routine; selected cases only |
MDMA-assisted therapy is investigational and was not approved by the FDA in 2024.
Adjustment disorder — brief supportive psychotherapy, problem-solving, stress management; identify the stressor and strengthen coping skills. Prolonged grief disorder — grief-focused psychotherapy (e.g., prolonged grief therapy). RAD and DSED — stable, responsive caregiving (placement, caregiver training).
Listed in priority order.
Common nursing diagnoses: post-trauma syndrome; anxiety; ineffective coping; risk for suicide; disturbed sleep pattern; complicated grieving.
| Complication | What to watch for |
|---|---|
| Suicide | Hopelessness, guilt, substance use, anniversary dates |
| Substance use disorder | Escalating alcohol or drug use |
| Violence, aggression | Irritability, hypervigilance, intimate partner conflict |
| Depression | Persistent low mood, anhedonia |
| Chronic PTSD, disability | Untreated symptoms, ongoing avoidance |
| Syncope | First doses of prazosin |
| Revictimization | Ongoing abusive relationship |
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.